Found 30 matching trials
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment PHASE1 This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma PHASE2 The current study is an investigator-initiated, single-arm phase 2 study th...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. PHASE2 Phase II clinical study of irinotecan liposome (II)-based combination regim...
Show More Location
Chinese PLA General Hospital, Beijing,
Learn More & Join Trial
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab PHASE2 Guidelines recommend FOLFIRI in combination with bevacizumab or cetuximab a...
Show More Location
The second affiliated hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies PHASE2 This Phase II, single-arm, single-center study evaluates the conversion to ...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer PHASE2 The study explores the efficacy and safety of oxaliplatin combined with iri...
Show More Location
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer PHASE2 This is an open label, randomized phase 2 study of NaliCap (irinotecan lipo...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer PHASE2 To evaluate the objective response rate, disease control rate, progression-...
Show More Location
West China Hospital,Sichuan University
Learn More & Join Trial
A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC PHASE2 This is an open-label, single-arm, prospective phase 2 study, evaluating th...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer PHASE2 Patients with previously untreated advanced or metastatic esophageal squamo...
Show More Learn More & Join Trial